“If all goes well I could imagine that we gain approval in the second half of December and start deliveries before Christmas, but really only if all goes positively,” he said. Of the 170 volunteers who contracted Covid-19 in Pfizer’s trial involving over 43,000 people, 162 had received a placebo and not the vaccine, meaning the vaccine was 95% effective. Covid-19 runs rampantThe final trial analysis comes a week after initial results showed the vaccine was more than 90% effective. Global shares rose as the trial results countered concerns around the soaring infection rate. Moderna and J&J have said they hope to start testing the vaccine in younger people soon.

Source: Hindustan Times November 19, 2020 04:14 UTC